Form 4: Guardant Health's Chief Technology Officer Reports Stock Transactions
SEC Form 4 Filing
Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On July 1, 2024, Darya Chudova, the Chief Technology Officer of Guardant Health, Inc., reported transactions involving common stock.
- These transactions included the vesting of 1,339 restricted stock units and the withholding of 478 shares by the company to cover tax obligations.
- Following these transactions, Chudova directly owns 44,063 shares of Guardant Health common stock and 12,053 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock-based awards, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they relate to executive compensation and do not represent a significant change in ownership.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of restricted stock unit award grant. |
| October 1, 2023 | 25% of the shares subject to the restricted stock unit award vested. |
| July 1, 2024 | Date of stock transactions: vesting of restricted stock units and tax withholding. |
| July 2, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.